RespireRx Pharmaceuticals Inc (fka RSPI)

[ombowstring]

Karl, maybe you are right in what Mark was referring to with his use of the word "financing".

But, this is from Neuro's post #21701:

"...the fiscal meltdown has change the climate for partnering, financing, and M&A. There is an undercurrent of fear at this meeting [Windhover] that is not like anything I have seen in several years. One statistic is that there are over 120 biotechs with less than six months of cash--Cortex is among them. Which means that every Big Pharma can step back and reconsider all of its plans, because they have a menu of options they could not have dreamt of a few months ago, And as one major pharma executive said--he's waiting for biotechs to begin to accept that their valuations are 50% of what they were before the "crash", and to accept offers based on these valuations, not on what they were previously."